Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study.
Saved in:
| Title: | Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study. |
|---|---|
| Authors: | Leonardi C; Central Dermatology, St. Louis, Missouri. Electronic address: Craig.Leonardi@centralderm.com., Maari C; Innovaderm Research Inc, Montreal, Quebec, Canada; Medical University of Graz, Graz, Austria., Philipp S; Charité Universitätsmedizin Berlin, Berlin, Germany., Goldblum O; Eli Lilly and Company, Indianapolis, Indiana., Zhang L; Eli Lilly and Company, Indianapolis, Indiana., Burkhardt N; Eli Lilly and Company, Indianapolis, Indiana., Ball S; Eli Lilly and Company, Indianapolis, Indiana., Mallbris L; Eli Lilly and Company, Indianapolis, Indiana., Gonzalez P; Buenos Aires Skin SA, Buenos Aires, Argentina., Fernández-Peñas P; Department of Dermatology, Westmead Hospital Dermatology Service, The University of Sydney, Westmead, Australia., Puig L; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. |
| Source: | Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2018 Nov; Vol. 79 (5), pp. 824-830.e2. Date of Electronic Publication: 2018 May 25. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
